Stay updated on Pembrolizumab in Advanced Penile Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Penile Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedLocations are now presented under a single Locations header listing Alabama, California, and Georgia; the separate Alabama Locations, California Locations, and Georgia Locations sections were removed. The HHS Vulnerability Disclosure footer link has been removed in the update.SummaryDifference0.5%

- Check47 days agoChange DetectedThe change is a minor revision label update on the page (from v3.3.1 to v3.3.2) with no impact on the study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.3.1 is now displayed, replacing v3.2.0. This is a minor administrative update and does not alter study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved a site-wide government funding status notice about NIH operations and potential processing delays. No study-related content was added or changed.SummaryDifference0.4%

- Check76 days agoChange DetectedNo significant changes observed between the two screenshots; the page content and layout appear unchanged.SummaryDifference0.5%

- Check104 days agoChange DetectedUpdated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.SummaryDifference3%

Stay in the know with updates to Pembrolizumab in Advanced Penile Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.